ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The tremendous clinical potential of the microbiota in the treatment of breast cancer: the next frontier

Wu, Yang; Zhang, Yue; Zhang, Wenwen; Huang, Yuanxi; Lu, Xiangshi; Shang, Lingmin; Zhou, Zhaoyue; Chen, Xiaolu; Li, Shuhui; Cheng, Shaoqiang*; Song, Yanni*哈尔滨医科大学
Journal of Cancer Research and Clinical Oncology2023-6-29DOI: 10.1007/s00432-023-05014-4
8阅读
引用收藏
分享

摘要

Although significant advances have been made in the diagnosis and treatment of breast cancer (BC) in recent years, BC remains the most common cancer in women and one of the main causes of death among women worldwide. Currently, more than half of BC patients have no known risk factors, emphasizing the significance of identifying more tumor-related factors. Therefore, we urgently need to find new therapeutic strategies to improve prognosis. Increasing evidence demonstrates that the microbiota is present in a wider range of cancers beyond colorectal cancer. BC and breast tissues also have different types of microbiotas that play a key role in carcinogenesis and in modulating the efficacy of anticancer treatment, for instance, chemotherapy, radiotherapy, and immunotherapy. In recent years, studies have confirmed that the microbiota can be an important factor directly and/or indirectly affecting the occurrence, metastasis and treatment of BC by regulating different biological processes, such as estrogen metabolism, DNA damage, and bacterial metabolite production. Here, we review the different microbiota-focused studies associated with BC and explore the mechanisms of action of the microbiota in BC initiation and metastasis and its application in various therapeutic strategies. We found that the microbiota has vital clinical value in the diagnosis and treatment of BC and could be used as a biomarker for prognosis prediction. Therefore, modulation of the gut microbiota and its metabolites might be a potential target for prevention or therapy in BC.

学科与关键词

关键词
Breast cancerMicrobiotaMechanismsTherapy
相关
加载中…
  • Review Redrawing therapeutic boundaries: microbiota and cancer
    Sholl, Jonathan*; Sepich-Poore, Gregory D.; Knight, Rob; Pradeu, Thomas*Trends in Cancer, 2022, 8(2): 87-97.被引 14
  • Current Understanding of Microbiomes in Cancer Metastasis
    Liu, Jiaqi; Luo, Feiyang; Wen, Liyan; Zhao, Zhanyi; Sun, Haitao*Cancers, 2023, 15(6): 1893.被引 3
  • The microbiome(s) and cancer: know thy neighbor(s)
    Paloma, González‐Sánchez; Gina M., DeNicolaJournal of Pathology, 2021, path.5661.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cancer Research and Clinical Oncology
发表日期
2023-06-29
DOI
10.1007/s00432-023-05014-4
语言
ENGLISH
成果收录
SCIE
资助标注
Beijing Medical Award Foundation [YXJL-2020-1225-0323]; Beijing MDK Public Welfare Foundation Research Fund [MDK-2022-1001]; Heilongjiang Natural Science Foundation of China [JJZD2020-04]; Postdoctoral Scientific Research Developmental Fund of Heilongjiang [LBH-Q22]

作者

  • W

    Wu, Yang (第一作者)

    harbin med univ

  • Z

    Zhang, Yue

    harbin med univ

查看全部 11 位作者收起作者
  • Z

    Zhang, Wenwen

    harbin med univ

  • H

    Huang, Yuanxi

    harbin med univ

  • L

    Lu, Xiangshi

    harbin med univ

  • S

    Shang, Lingmin

    harbin med univ

  • Z

    Zhou, Zhaoyue

    harbin med univ

  • C

    Chen, Xiaolu

    harbin med univ

  • L

    Li, Shuhui

    harbin med univ

  • C

    Cheng, Shaoqiang (通讯)

    harbin med univ

  • S

    Song, Yanni (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417